Jefferies Raises Core Scientific Price Target to 37 Citing AI Infrastructure Demand Growth
Inflation Pressures Broaden Beyond Iran and Oil Shelter and Services Show Renewed Price Increases
Q4 Earnings Roundup EID Parry Reports Loss Marksans Pharma and Astra Microwave See Profit Gains AIA Engineering Declines
Jim Cramer Expresses Disappointment Over Toll Brothers Outlook
Over OneThird of TwoYear Mutual Fund SIPs Report Losses Market Timing and Sector Selection Matter
Custard Apple Hardy Plant Fragile Fruit Poses Export Challenge
GWAV Q3 2023 Earnings Loss per Share Reported at 175 as Company Focuses on Operational Improvements
WFRD Q1 2026 Earnings EPS Surges Past Estimates by 39 Stock Declines Slightly
ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains
DNLI Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Stock Reaction
Verastem Q1 2026 Earnings NarrowerthanExpected Loss Beats Estimates Stock Edges Higher
PRTH Q1 2026 Earnings EPS Surpasses Estimates by 277 Despite Modest Share Decline
Banzai International BNZI Slips 172 as Stock Tests Key Support Near 381
Tvardi Therapeutics TVRD Holds Steady Near Support Amid LowVolume Trading
Columbia Sportswear COLM Rallies 38 as Shares Bounce From Key Support Level
LanzaTech Global LNZA Slides 72 as Resistance Holds Firm Key Support in Focus
RTX Corporation RTX Gains 137 as Defense Sector Shows Resilience
Manufacturing Employment Data Underscore Uneven Impact of TrumpEra Tariffs Cato Institute Analysis Suggests
PMCB Q1 2026 Earnings PreRevenue Biotech Reports Negative EPS Stock Rises on Potential Pipeline Progress
Pan American Silver PAAS Slips 26 as Silver Prices Weigh Support at 5124 in Focus
Fortress Biotech Preferred Shares FBIOP Advance 245 as Support Holds Near 16
Andersons Inc ANDE Edges Higher as Support Holds Resistance Test Potentially Ahead
Crown Reserve Acquisition Corp I Rights CRACR Holds Steady at 015 Amid Limited Trading Activity
Xenetic Biosciences XBIO Edges Lower Amid Tight Trading Range
Huadi International Group HUDI Faces Steep Decline Testing Key Support at 10
Cardiol Therapeutics Inc CRDL Modestly Advances as It Holds Above Key Support
Corbus Pharmaceuticals CRBP Slides 14 as Key Support Level Comes into Focus